Study finds stereotactic body radiotherapy is safe for treating multiple metastases
A new study identifies interleukin 11 as a marker of cancer-associated fibroblasts
22 April 2021Antidepressants: Evidence on safe discontinuation is lacking, concludes Cochrane review
22 April 2021Study finds stereotactic body radiotherapy is safe for treating multiple metastases
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases. The study was run through NRG Oncology and sponsored by the National Cancer Institute. The results were published on April 22 in JAMA Oncology.
